Activation, activity and inactivation of factor VIII in factor VIII products.

about

Effects of an acidic environment on coagulation dynamics.

P2860

Q51633018-75255B3F-08ED-4E19-8F1A-C58F00EAE731

P2860

Activation, activity and inactivation of factor VIII in factor VIII products.

Item

http://www.wikidata.org/entity/Q40045886

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Activation, activity and inactivation of factor VIII in factor VIII products.

@en

type

Item

label

Activation, activity and inactivation of factor VIII in factor VIII products.

@en

prefLabel

Activation, activity and inactivation of factor VIII in factor VIII products.

@en

P1476

Activation, activity and inactivation of factor VIII in factor VIII products.

@en

P2093

K G Mann

http://www.w3.org/2001/XMLSchema#string

M Gissel

http://www.w3.org/2001/XMLSchema#string

R Elsman

http://www.w3.org/2001/XMLSchema#string

S Butenas

http://www.w3.org/2001/XMLSchema#string

T Orfeo

http://www.w3.org/2001/XMLSchema#string

P2860

Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity

Anticoagulants and the propagation phase of thrombin generation

Defining the boundaries of normal thrombin generation: investigations into hemostasis

Activation of factor VIII and mechanisms of cofactor action.

The tissue factor requirement in blood coagulation.

The plasma hemostatic proteome: thrombin generation in healthy individuals.

Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.

First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development.

First and next generation native rFVIII in the treatment of hemophilia A. What has been achieved? Can patients be switched safely?

Isolation of functional human coagulation factor V by using a hybridoma antibody

P304

462-473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HAE.12872

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26822998

http://www.w3.org/2001/XMLSchema#string

Activation, activity and inactivation of factor VIII in factor VIII products.

about

P2860

P2860

Activation, activity and inactivation of factor VIII in factor VIII products.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698